You searched for: chlamydophila (Engelska - Danska)

chlamydophila spp.
chlamydophila arter

attenuated feline chlamydophila
svækket felin chlamydophila felis

attenuated chlamydophila felis (905 strain).
svækket chlamydophila felis (905- stamme).

inactivated chlamydophila felis (cello strain)
inaktiveret felint chlamydia felis (cello- stamme)

chlamydophila felis (905 strain) ..........................................................................................  103.0 eid50
chlamydophila felis (905 stamme) .......................................................................................  103,0 eid50

-against chlamydophila felis infection to reduce clinical signs,
· mod chlamydophila felis infektion for at reducere kliniske tegn

2.0 elisa u.attenuated chlamydophila felis (905 strain) .....................................................................
svækket chlamydophila felis (905 stamme) .................................................................... 103, 0 eid502 svækket felin panleukopeni virus (pli iv) ..................................................................... 103, 5 ccid501 hjælpestoffer:

attenuated chlamydophila felis (905 strain).................................................................... ≥ 103.0 eid502 excipient:
svækket chlamydophila felis (905 stamme).................................................................... > 103, 0 eid502 hjælpestof:

stimulates active immunity against feline rhinotracheitis herpesvirus, feline calicivirus and chlamydophila felis.
stimulerer aktivt immuniteten over for felin rhinotracheitis herpesvirus, felin calici virus og chlamydophila felis.

tho moraxella catarrhalis* other chlamydophila pneumoniae*au chlamydia psittaci mycoplasma pneumoniae*
ise andre chlamydophila pneumoniae * chlamydia psittaci mycoplasma pneumoniae *

against calicivirus infection to reduce clinical signs, against chlamydophila felis infection to reduce clinical signs,
mod calicivirus infektion for at reducere kliniske tegn, mod chlamydophila felis infektion for at reducere kliniske tegn,

against calicivirus infection to reduce clinical signs and excretion, against chlamydophila felis infection to reduce clinical signs.
mod calicivirus infektion for at reducere kliniske tegn og virusudskillelse mod chlamydophila felis infektion for at reducere kliniske tegn

if the control of chlamydophila is desired, 0,05 to 0,1 mg/ml oxytetracycline must be included.
hvis der ønskes kontrol af chlamydophila, skal der desuden tilsættes 0,05–0,1 mg/ml oxytetracyclin.

attenuated feline herpesvirus, chlamydophila felis, feline panleucopenia virus and felv recombinant canarypox virus (vcp97):
svækket felin herpesvirus, chlamydophila felis, felin panleukopeni virus og felv rekombinant canarypox virus (vcp97):

stimulates active immunity against feline rhinotracheitis herpesvirus, feline calicivirus, chlamydophila felis, feline panleucopenia virus and feline leukaemia virus.
stimulerer aktivt immuniteten over for felin rhinotracheitis herpesvirus, felin calicivirus, chlamydophila felis, felin panleukopeni virus og felin leukæmivirus.

against calicivirus infection to reduce clinical signs, against chlamydophila felis infection to reduce clinical signs, against feline panleucopenia to prevent mortality and clinical signs.
mod calicivirus infektion for at reducere kliniske tegn, mod chlamydophila felis infektion for at reducere kliniske tegn, mod felin panleukopeni til forebyggelse af dødsfald og kliniske tegn.

attenuated feline herpesvirus and chlamydophila felis:merial laboratory of lyon porte des alpes rue de l'aviation 69800 saint-priest france
svækket felin herpesvirus og chlamydophila felis merial laboratory of lyon porte des alpes rue de l'aviation 69800 saint-priest frankrig

the duration of immunity after the last re-vaccination is 3 years for the rhinotracheitis, calicivirosis and panleucopenia components, and 1 year for the chlamydophila felis and feline leukaemia components.
varigheden af immunitet efter sidste revaccination er 3 år for rhinotracheitis, calicivirus og panleukopeni komponenterne og 1 år for chlamydophila felis og felin leukæmi komponenterne.

onsets of immunity have been demonstrated 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.
15 det er vist, at immuniteten indtræder 1 uge efter basisvaccination for rhinotracheitis, calicivirus, chlamydophila felsi og, panleukopeni samt 2 uger efter basisvaccination for felin leukæmi.

15 the duration of immunity is 1 year after the last (re-)vaccination for rhinotracheitis, calicivirus, chlamydophila felis and feline leukaemia components, and 3 years for panleucopenia component
varigheden af immunitet er 1 år efter sidste (re -) vaccination for rhinotracheitis, calicivirus, chlamydophila felis og felin leukæmi og 3 år for panleukopeni.